Delivery Order SPE2DB24D1034-SPE2DB25FVZY7

Award Date 1/22/25
Potential Completion Date 1/23/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, valued at $2,155.95, is for the delivery of Carvedilol ER 20 mg capsules. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 21, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,823.91 firm fixed-price delivery order contract is for the supply of Carvedilol ER 20 mg capsules. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 20 mg capsules, with a total ceiling value of $12,368.06 and a completion date of June 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,011.54, is a delivery order for the supply of 80 mg Carvedilol ER capsules. The contract has a firm fixed price and an ultimate completion date of January 3, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Carvedilol ER 20 mg capsules. The contract has a ceiling value of $3,887.69 and a completion date of December 13, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,208.77 firm fixed-price delivery order is for the supply of Carvedilol ER 20 mg capsules. The contract has an ultimate completion date of June 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $10,356.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 20 mg capsules, a cardiovascular medication, to support military healthcare programs. The award is a firm fixed-price delivery order with a completion date of January 3, 2025. This contract is not designated as a set-aside and represents an open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,066.14 firm fixed-price delivery order is for the supply of Carvedilol ER 10 mg capsules, a cardiovascular medication. The contract has a completion date of November 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,500.28, is for the delivery of Carvedilol ER 10 mg capsules. The contract is a Firm Fixed Price Delivery Order with a completion date of June 5, 2024. The contract is not a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,595.34 firm fixed price delivery order covers the supply of Carvedilol ER 40 mg capsules to support military healthcare programs. The contract has an ultimate completion date of February 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB25FVZY7
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $2,304.99, is for the delivery of Carvedilol ER 20 mg capsules. This is a firm fixed-price delivery order contract with an ultimate completion date of January 23, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities across multiple therapeutic domains. Additionally, AmerisourceBergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, is responsible for delivering the specified pharmaceutical product to support the DLA's mission of providing medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 4/27/25, 12:59 AM